Ningxia Eppen Biotech Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Employees
-
3,798
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
- Investments
-
1
Ningxia Eppen Biotech General Information
Description
Provider of bio-amino acid products designed for food nutrition, animal and plant farming. The company's main products include amino acids, monosodium glutamate, corn by-products, compound fertilizer and other agricultural chemicals, enabling agriculture and food industry users to realize sustainable and eco-friendly growth.
Contact Information
Website
www.eppen.com.cn(Operating Subsidiary)
Corporate Office
- Yanghe Industry Park
- Yongning
- Yinchuan, Ningxia 750100
- China
Corporate Office
- Yanghe Industry Park
- Yongning
- Yinchuan, Ningxia 750100
- China
Ningxia Eppen Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ningxia Eppen Biotech Patents
Ningxia Eppen Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026145083-A1 | Use of ncgl0762 protein and mutant thereof in production of l-isoleucine | Pending | 31-Dec-2024 | ||
| WO-2026138946-A1 | Promoter ep10 and use thereof in preparation of l-lysine | Pending | 27-Dec-2024 | ||
| WO-2026138947-A1 | Promoter ep11, and related biomaterial and use thereof | Pending | 27-Dec-2024 | ||
| WO-2026021181-A1 | Promoter, and related biological material thereof and use thereof | Pending | 24-Jul-2024 | ||
| WO-2025252103-A1 | Use of pncgl1855 (a244c) promoter and biomaterial related thereto in preparation of l-lysine | Pending | 06-Jun-2024 | C07K14/34 |
Ningxia Eppen Biotech Signals
Ningxia Eppen Biotech Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ningxia Eppen Biotech Investments (1)
Ningxia Eppen Biotech’s most recent deal was a Joint Venture with Joint Venture (Agritek Bio, Tatneft and Ningxia Eppen Biotech). The deal was made on 31-Oct-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Joint Venture (Agritek Bio, Tatneft and Ningxia Eppen Biotech) | 31-Oct-2025 | Joint Venture | Agricultural Chemicals |
Ningxia Eppen Biotech FAQs
-
When was Ningxia Eppen Biotech founded?
Ningxia Eppen Biotech was founded in 1999.
-
Where is Ningxia Eppen Biotech headquartered?
Ningxia Eppen Biotech is headquartered in Yinchuan, China.
-
What is the size of Ningxia Eppen Biotech?
Ningxia Eppen Biotech has 3,798 total employees.
-
What industry is Ningxia Eppen Biotech in?
Ningxia Eppen Biotech’s primary industry is Agricultural Chemicals.
-
Is Ningxia Eppen Biotech a private or public company?
Ningxia Eppen Biotech is a Private company.
-
What is the current valuation of Ningxia Eppen Biotech?
The current valuation of Ningxia Eppen Biotech is .
-
What is Ningxia Eppen Biotech’s current revenue?
The current revenue for Ningxia Eppen Biotech is .
-
How much funding has Ningxia Eppen Biotech raised over time?
Ningxia Eppen Biotech has raised $34M.
-
Who are Ningxia Eppen Biotech’s investors?
Hosen Capital and Midea Venture have invested in Ningxia Eppen Biotech.
-
When was Ningxia Eppen Biotech acquired?
Ningxia Eppen Biotech was acquired on 23-Nov-2022.
-
Who acquired Ningxia Eppen Biotech?
Ningxia Eppen Biotech was acquired by Star Lake Bioscience Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process